The results showed that the changes in the esophageal cancer cell cycle could be significantly affected by the low expression of IPO5, and the growth of esophageal cancer was inhibited, possibly through the activation of the RAS-ERK pathway, which leads to epithelial-mesenchymal transformation and thus causes the occurrence of esophageal cancer. The gene discussed is IPO5; the disease is esophageal cancer.